Skip to content
Triangle logo TriangleGet started
← All settings

DISEASE & TREATMENT SETTING

Uterine Carcinosarcoma

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Uterine Carcinosarcoma

Source population
Not part of this definition
Disease extent
Not part of this definition
Treatment line
Not part of this definition
Stage
Not part of this definition
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
      derivation status
      source-attested
      derivation note
      Added because the terminology and the registry both attest it: an NCIt neoplasm concept named by 13 acquired study condition(s). It is absent from the NCI treatment-topic directory, which is not an exhaustive cancer inventory.
      source wording
      Source null

      Study evidence for this setting

      14 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

      NCT00025506 · Registry condition search · Scope: narrower

      Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus

      6 outcome links · 1 safety-group records · 1 quality-of-life measures

      →

      NCT00075400 · Registry condition search · Scope: narrower

      Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer

      6 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00114218 · Registry condition search · Scope: narrower

      Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer

      2 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00238121 · Registry condition search · Scope: narrower

      Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer

      4 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00245102 · Registry condition search · Scope: narrower

      Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma

      1 outcome links · 6 safety-group records · 0 quality-of-life measures

      →

      NCT00390234 · Registry condition search · Scope: narrower

      Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma

      5 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00659360 · Registry condition search · Scope: narrower

      AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma

      6 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00954174 · Registry condition search · Scope: narrower

      Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

      6 outcome links · 2 safety-group records · 4 quality-of-life measures

      →

      NCT01010126 · Registry condition search · Scope: narrower

      Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

      6 outcome links · 6 safety-group records · 0 quality-of-life measures

      →

      NCT01061606 · Registry condition search · Scope: narrower

      Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus

      6 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT01168232 · Registry condition search · Scope: narrower

      Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer

      4 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT01247571 · Registry condition search · Scope: narrower

      Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer

      5 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT01367301 · Registry condition search · Scope: narrower

      Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer

      1 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT03422198 · Registry condition search · Scope: narrower

      Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer

      6 outcome links · 2 safety-group records · 3 quality-of-life measures

      →
      Source relationships and population-mapping limitations
      bindings
      1. release id
        clinical-indications-draft-1
        disease state id
        ds-uterine-carcinosarcoma
        binding id
        ncit-C223978
        source collection
        ncit-concept
        source key
        C223978
        source excerpt
        Source null
        match status
        exact
        match note
        Source null
        recorded at
        2026-09-10T00:00:00Z
      mappings

        Download this complete draft source relationship record →

        Preserved source evidence · Not medical advice